This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1DN Frank , AL St Amand , RA Feldman , (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. PNAS 104, 13780–13785.
5L Zhao & J Shen (2010) Whole-body systems approaches for gut-microbiota-targeted, preventive healthcare. J Biotechnol 149, 183–190.
6S Zeissig , C Bojarski , N Buergel , (2004) Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor α antibody treatment. Gut 53, 1295–1302.
7NA Hering , A Fromm , EA van Tol , (2010) Transforming growth factor-α, a whey protein component, strengthens the intestinal barrier by upregulating claudin-4 in HT/29/B6 cells. J Nutr 141, 783–789.
9M Amasheh , A Fromm , SM Krug , (2010) TNF-α induced and berberine-antagonized tight junction barrier impairment via tyrosine kinas, Akt and NFκB signalling. J Cell Science 123, 4145–4155.
10J Raes & P Bork (2008) Molecular eco-systems biology: towards a better understanding of community function. Nat Rev Microbiol 6, 693–699.
11PJ Turnbaugh , RE Ley , M Hamady , (2007) The human microbiome project. Nature 449, 804–810.
12J Qin , R Li , J Raes , (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59–65.
13M Arumugam , J Raes , E Pelletier , (2011) Enterotypes of the human gut microbiome. Nature 473, 174–180, .
14J Zwielehner , K Liszt , M Handschur , (2009) Combined PCR-DGGE fingerprinting and quantitative-PCR indicates shifts in fecal population sizes and diversity of Bacteroides, bifidobacteria and Clostridium cluster IV in institutionalized elderly. Exp Gerontol 44, 440–446.
15K Liszt , J Zwielehner , M Handschur , (2009) Characterization of bacteria, clostridia and Bacteroides in faeces of vegetarians using qPCR and PCR-DGGE fingerprinting. Ann Nutr Metab 54, 253–257.
16JB Greer & SJ O'Keefe (2011) Microbial induction of immunity, inflammation, and cancer. Front Physiol 1, 168.
18AW Walker , J Ince , SH Duncan , (2011) Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J 5, 220–230.
19SH Duncan , A Belenguer , G Holtrop , (2007) Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol 73, 1073–1078.
20WR Russell , S Gratz , SH Duncan , (2011) High protein, reduced carbohydrate diets promote metabolite profiles likely to be detrimental to colonic health. Am J Clin Nutr 93, 1062–1072.
21P Louis , P Young , G Holtri , (2010) Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. Environ Microbiol 12, 304–314.
22B Hippe , J Zwielehner , K Liszt , (2011) Quantification of butyryl CoA-transferase genes reveals different butyrate production capacity in individuals according to diet and age. FEMS Microbiol Lett 316, 130–135.
23RH Sandler , SM Finegold , ER Bolte , (2000) Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol 15, 429–435.
24A Klinder , A Forster , G Caderni , (2004) Fecal water genotoxicity is predictive of tumor-preventive activities by inulin-like oligofructoses, probiotics (Lactobacillus rhamnosus and Bifidobacterium lactis) and their synbiotic combination. Nutr Cancer 49, 144–155.
25PD Cani , J Amar , MA Iglesias , (2007) Metabolic endotoxaemia initiates obesity and insulin-resistance. Diabetes 56, 1761–1772.
26M Li , B Wang , M Zhang , (2008) Symbiotic gut microbes modulate human metabolic phenotypes. PNAS 105, 2117–2122.
27PD Cani & NM Delzenne (2009) Interplay between obesity and associated metabolic disorders: new insights in the gut microbiota. Curr Opin Pharmacol 9, 737–743.
28C Zhang , M Zhang , S Wang , (2010) Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndrome in mice. ISME J 4, 232–241.
29K Atarashi , J Nishimura , T Shima , (2008) ATP drives lamina propria TH17 cell differentiation. Nature 455, 808–814.
30At Ivanov II, K arashi , N Manel , (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139, 485–498.
31K Atarashi , T Tanoue , T Shima , (2011) Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331, 337–341.
32H Sokol , B Pigneur , L Watterlot , (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. PNAS 105, 16731–16736.
33SM Collins & P Bercic (2009) The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 136, 2003–2014.
34R Spiller & K Garsed (2009) Postinfectious irritable bowel syndrome. Gastroenterology 136, 1979–1988.
35G Barbara , V Stanghellini , G Brandi , (2005) Interactions between commensal bacteria and gut sensorimotor function in health and disease. Am J Gastroenterol 100, 2560–2568.
37SM O'Mahony , JR Marchesi , P Scully , (2008) Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry 65, 263–267.
38AM Schoepfer , T Schaffer , B Seibold-Schmid , (2008) Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients. Neurogastroenterol Motil 20, 1110–1118.
39GA Preidis & J Versalovic (2009) Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology 136, 2015–2031.
40P Moayyedi , AC Ford , NJ Talley , (2010) The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 59, 325–332.
41M Pimentel , S Park , J Mirocha , (2006) The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med 145, 557–563.
43A Kassinen , L Krogius-Kurikka , H Mäkivuokko , (2007) The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 133, 24–33.
44A Lyra , T Rinttilä , J Nikkilä , (2009) Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification. World J Gastroenterol 15, 5936–5945.
45E Malinen , T Rintatilä , K Kajander , (2005) Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 100, 373–382.
46M Simrén & PO Stotzer (2006) Use and abuse of hydrogen breath tests. Gut 55, 297–303.
47H-R Lee & M Pimentel (2006) Bacteria and irritable bowel syndrome: the evidence for small intestinal bacterial overgrowth. Curr Gastroenterol Rep 8, 305–311.
48NH Salzman , MA Underwood & CL Bevins (2007) Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa. Semin Immunol 19, 70–83.
49J Langhorst , A Junge , A Rueffer , (2009) Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome. Am J Gastroenterol 104, 404–410.
50JR Turner (2009) Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 9, 799–809.
51T Piche , G Barbara , P Aubert , (2009) Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut 58, 196–201.
52G Barbara , V Stanghellini , R De Giorgio , (2004) Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 126, 693–702.
53G Barbara , B Wang , V Stanghellini , (2007) Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 132, 26–37.
54A Spor , O Koren & R Ley (2011) Unravelling the effects of the environment and host genotype on the gut microbiome. Nat Rev Microbiol 9, 279–289.
56M Abreu (2010) Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol 10, 131–444.
57D Haller , MP Russo , RB Sartor , (2002) IKKβ and phosphatidylinositol 3-kinase/Akt participate in non-pathogenic Gram-negative enteric bacteria-induced ReIA phosphorylation and NF-κB activation in both primary and intestinal epithelial cells. J Biol Chem 277, 38168–38178.
58PA Ruiz , A Shkoda , SC Kim , (2005) IL-10 gene-deficient mice lack TGF-β/Smad signalling and fail to inhibit proinflammatory gene expression in intestinal epithelial cells after the colonisation with colitogenic Enterococcus faecalis. J Immunol 174, 2990–2999.
60A Kaser , S Zeissig & RS Blumberg (2010) Inflammatory bowel disease. Ann Rev Immunol 28, 573–621.
61N Steck , M Hoffmann , IG Sava , (2011) Enterococcus faecalis metalloprotease compromises epithelial barrier and contributes to intestinal inflammation. Gastroenterology 141, 959–971.
62S Lebeer , J Vanderleyden & SCJ De Keersmaecker (2010) Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol 8, 171–184.
63T Clavel & D Haller (2007) Bacteria- and host-derived mechanisms to control intestinal cell homeostasis: implications for chronic inflammation. Inflamm Bowel Dis 13, 1153–1164.
64T Werner , SJ Wagner , I Martinez , (2011) Depletion of luminal iron alters the gut microbiota and prevents Crohn's disease-like ileitis. Gut 60, 325–333.
65EJ Schiffrin , F Rochat , H Link-Amster , (1995) Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 78, 491–497.
66European Food Safety Authority (2011) Guidance on the scientific requirements for health claims related to gut and immune function. EFSA J 9, 1984.
67D Bunout , G Barrera , S Hirsch , (2004) Effects of a nutritional supplement on the immune response and cytokine production in free-living Chilean elderly. JPEN J Parenter Enteral Nutr 28, 348–354.
68T Boge , M Rémigy , S Vaudaine , (2009) A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine 27, 5677–5684.
69M Olivares , MP Díaz-Ropero , S Sierra , (2007) Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. Nutrition 23, 254–260.
70LE Davidson , AM Fiorino , DR Snydman , (2011) Lactobacillus GG as an immuneadjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double-blind placebo-controlled trial. Eur J Clin Nutr 65, 501–507.
71L Van Overtvelt , H Moussu , S Horiot , (2010) Lactic acid bacteria as adjuvants for sublingual allergy vaccines. Vaccine 28, 2986–2992.
72ML Callegari , B Riboli , JW Sanders , (1998) The S-layer gene of Lactobacillus helveticus CNRZ 892: cloning, sequence and heterologous expression. Microbiology 144, 719–726.
73SR Konstantinov , H Smidt , WM de Vos , (2008) S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. PNAS 105, 19474–19479.
74S Voltan , D Martines , M Elli , (2008) Lactobacillus crispatus M247-derived H2O2 acts as a signal transducing molecule activating peroxisome proliferator activated receptor-gamma in the intestinal mucosa. Gastroenterology 135, 1216–1227.
75F Boyle & J Ferlay (2005) Cancer incidence and mortality in Europe, 2004. Annals Oncol 16, 481–488.
77D Commane , R Hughes , C Shortt , (2005) The potential mechanisms involved in the anti-carcinogenic action of probiotics. Mutat Res 591, 276–289.
79A Kawano , H Ishikawa , T Nakamura , (2010) Evaluation of epidemiological studies of intestinal bacteria that affected occurrence of colorectal cancer: studies on prevention of colorectal tumours by dairy products and lactic acid bacteria. Nippon Eiseigaku Zasshi 65, 422–446.
81H Ishikawa , I Akedo , T Otani , (2005) Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumours. Int J Cancer 116, 762–767.
82AP Femia , C Luceri , P Dolara , (2002) Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 23, 1953–1960.
84V Neville , M Gleeson & JP Folland (2008) Salivary IgA as a risk factor for upper respiratory infections in elite professional athletes. Med Sci Sports Exerc 40, 1228–1236.
85M Gleeson (2007) Exercise and immune function. J Appl Physiol 103, 693–699.
87SM Simons & RG Kennedy (2004) Gastrointestinal problems in runners. Curr Sports Med Rep 3, 112–116.
88AE Jeukendrup , K Vet-Joop , A Sturk , (2000) Relationship between gastro-intestinal complaints and endotoxaemia, cytokine release and the acute-phase reaction during and after long-distance triathlon in highly trained men. Clin Sci 98, 47–55.
90E Tiollier , M Chennaoui , D Gomez-Merino , (2007) Effect of a probiotic supplementation on respiratory infections and immune and hormonal parameters during intense military training. Mil Med 172, 1006–1011.
91AJ Cox , DB Pyne , PU Saunders , (2010) Oral administration of the probiotic Lactobacillus fermentum VRI-003 and mucosal immunity in endurance athletes. Br J Sports Med 44, 222–226.
92M Gleeson , NC Bishop , M Oliveira , (2011) Daily probiotic's (Lactobacillus casei Shirota) reduction of infection incidence in athletes. Int J Sport Nutr Exerc Metab 21, 55–64.